| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/27/1998 | US5712117 Cytoplasmic antiproteinase-2 and coding sequences |
| 01/27/1998 | US5712115 Polynucleotide encoding polypeptide with amino acid sequences |
| 01/27/1998 | US5712113 Signal sequences for secretion of heterologous proteins from yeast |
| 01/27/1998 | US5712105 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody |
| 01/27/1998 | US5712104 Screening test for cancer, aids/hiv, influenza |
| 01/27/1998 | US5712100 Antibodies to peptides having NGF-like activity, and use thereof |
| 01/27/1998 | US5712089 Proteins and infecting bacteria |
| 01/26/1998 | CA2203745A1 Pro-protein converting enzyme |
| 01/22/1998 | WO1998002748A1 Methods to detect hk2 polypeptides |
| 01/22/1998 | WO1998002746A1 Peptide reagent for the detection of human cytomegalovirus (cmv) |
| 01/22/1998 | WO1998002559A1 Over-expression of proteins |
| 01/22/1998 | WO1998002547A2 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 01/22/1998 | WO1998002541A1 Gamma-heregulin |
| 01/22/1998 | WO1998002525A1 Pituitary differentiation factor and methods of use thereof |
| 01/22/1998 | WO1998002463A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCα RECEPTOR ANTIBODIES |
| 01/22/1998 | WO1998002459A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | WO1998002454A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 01/22/1998 | CA2436126A1 Subunit respiratory syncytial virus vaccine preparation |
| 01/22/1998 | CA2261019A1 Methods to detect hk2 polypeptides |
| 01/22/1998 | CA2260738A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | CA2260288A1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 01/22/1998 | CA2260079A1 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 01/22/1998 | CA2259371A1 Therapeutic multispecific compounds comprised of anti-fc.alpha. receptor antibodies |
| 01/22/1998 | CA2259136A1 Pituitary differentiation factor and methods of use thereof |
| 01/22/1998 | CA2255683A1 Over-expression of proteins |
| 01/21/1998 | EP0819757A2 Enzyme which activates an interferon-gamma inducing polypeptide |
| 01/21/1998 | EP0819701A1 Monoclonal antibody specifically recognizing adeno-associated virus cap protein |
| 01/21/1998 | EP0819254A1 Reagents and methods for the detection and quantification of vancomycin in biological fluids |
| 01/21/1998 | EP0819175A1 Novel promoters for expressing proteins of interest in yeast |
| 01/21/1998 | EP0819173A1 Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases |
| 01/21/1998 | EP0819172A1 Polynucleotide immunogenic agents |
| 01/21/1998 | EP0819171A1 Antibodies for the detection of hla-g |
| 01/21/1998 | EP0819170A1 Retroviral vectors |
| 01/21/1998 | EP0819168A1 Human tumor necrosis factor receptor |
| 01/21/1998 | EP0819167A2 Dna encoding galanin galr2 receptors and uses thereof |
| 01/21/1998 | EP0701628B1 Process for screening substances having a modulating effect on an interleukine-5-receptor-dependent cellular signal transmission path |
| 01/21/1998 | EP0701612B1 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS |
| 01/21/1998 | EP0504363B1 PURIFIED IgG ANTIBODIES |
| 01/21/1998 | CN1171134A Production of variant nisin |
| 01/21/1998 | CN1171133A Gene participating in apoptosis |
| 01/21/1998 | CN1171113A Mutants of Rb and p53 genes and uses thereof |
| 01/21/1998 | CN1171054A Compound |
| 01/21/1998 | CN1170761A Process for production of lipstatin and tetrahydrolipstatin |
| 01/20/1998 | US5710262 Nucleic acid encoding HB15 polypeptides |
| 01/20/1998 | US5710253 Method for decoloring human serum albumin |
| 01/20/1998 | US5710032 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them and their use |
| 01/20/1998 | US5710027 Process and vector for expressing alpha-interferon in E. coli |
| 01/20/1998 | US5710026 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences |
| 01/20/1998 | US5710024 Polynucleotides that encode the calcitonin gene-related peptide receptor coponent factor (HOUNDC44) |
| 01/20/1998 | US5710022 Nuclear mitotic phosphoprotein |
| 01/20/1998 | US5710018 Mammalian influx peptide transporter |
| 01/20/1998 | US5710017 DNA encoding a constitutive activator retinoic acid response (CAR) receptor |
| 01/20/1998 | US5710010 Assays for the presence of a mutant EGF receptor |
| 01/20/1998 | US5709996 Self-assembling recombinant papillomavirus capsid proteins |
| 01/20/1998 | US5709859 Complexes of fusion proteins; antitumor agent; antiinflammatory agents |
| 01/20/1998 | US5709858 To which they are capable of binding; specified amino acid sequences; medical diagnosis |
| 01/15/1998 | WO1998001582A1 Method for measuring viral infectivity |
| 01/15/1998 | WO1998001581A1 Method of dna shuffling with polynucleotides produced by blockingor interrupting a synthesis or amplification process |
| 01/15/1998 | WO1998001559A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/15/1998 | WO1998001554A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001553A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001552A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001549A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | WO1998001535A1 Method for the production of polypeptides |
| 01/15/1998 | WO1998001534A1 Novel methods and compositions for combinatorial-based discovery of new multimeric molecules |
| 01/15/1998 | WO1998001471A1 Methods for determining the presence of brain protein s-100 |
| 01/15/1998 | WO1998001460A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/15/1998 | WO1998001153A1 Medicinal compositions for extracorporeal blood circulation circuit and method for inhibiting blood coagulation in extracorporeal blood circulation circuit |
| 01/15/1998 | WO1998001145A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/15/1998 | CA2260368A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/15/1998 | CA2260360A1 Use of a panel of heterokaryons to produce variants of multimeric proteins |
| 01/15/1998 | CA2260295A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2260293A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259957A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259955A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259628A1 Method of dna shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process |
| 01/15/1998 | CA2259618A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | CA2259413A1 Methods for determining the presence of brain protein s-100 |
| 01/15/1998 | CA2259154A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/14/1998 | EP0818533A2 Novel isoform gene for focal adhesion protein paxillin |
| 01/14/1998 | EP0818532A1 Plant promoter and gene expression with the use of the same |
| 01/14/1998 | EP0818466A2 Purified, biologically active bacterially produced recombinant human CSF-1 |
| 01/14/1998 | EP0817855A1 Mutated proteins coded by a lentivirus mutated env gene, peptide fragments and expression vectors |
| 01/14/1998 | EP0817852A2 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein |
| 01/14/1998 | EP0817851A2 Dna encoding human papilloma virus type 18 |
| 01/14/1998 | EP0817848A1 In vivo generation of antibodies against antigens secreted in a host by transfected mel cells |
| 01/14/1998 | EP0817847A1 Il-17 receptor |
| 01/14/1998 | EP0817846A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 01/14/1998 | EP0817845A1 Conditional expression system |
| 01/14/1998 | EP0817835A1 Production of antibodies using cre-mediated site-specific recombination |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817798A1 Nucleotide and protein sequences of lats genes and methods based thereon |
| 01/14/1998 | EP0817646A2 Methods of treating inflammation and compositions therefor |
| 01/14/1998 | EP0817644A1 Treatment of papillomavirus-associated lesions using interleukin-12 |
| 01/14/1998 | EP0667916B1 Crf binding protein |
| 01/14/1998 | EP0661987B1 Morphogen-induced liver regeneration |
| 01/14/1998 | EP0659276B1 Immunoassay for detecting collagen or collagen fragments |
| 01/14/1998 | EP0394277B1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/14/1998 | EP0379556B1 Production of glucose oxidase in recombinant systems |
| 01/14/1998 | CN1170415A Cathepsin O2 protease |